<DOC>
	<DOCNO>NCT00981266</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness Mentor 's Spectra/Becker 80 Adjustable Breast Implants woman undergo primary revision breast augmentation . Safety information rate complication , infection , collect use help determine device safety . These implant investigational device . Approximately 450 patient sit across United States enrol research study 30 site . These patient implant Spectra/Becker 80 implant monitor 10 year collect information risk associate implant surgery well change way patient feel .</brief_summary>
	<brief_title>Spectra Breast Implant Study</brief_title>
	<detailed_description>Silicone gel-filled breast implant introduce early sixty wide-scale distribution time Medical Device Amendments Food Drug Cosmetic Act pass 1976 . In 1983 , gel-filled breast implant designate Class III device require premarket approval . In May 1990 , Food Drug Administration ( FDA ) publish propose request ( 515 ( b ) ) Pre-market Approval Applications ( PMA ) April 1991 publish final request . This final publication put manufacturer gel-filled breast implant notice continue market gel-filled breast implant , PMA due FDA 90 day final publication date . A Pre-Market Approval ( PMA ) Mentor gel-filled breast implant file FDA July 1991 . At FDA General Plastic Surgery Advisory Committee meet November 1991 , committee recommend submission additional information establish safety effectiveness gel-filled breast implant . In January 1992 , FDA Commissioner announce voluntary moratorium sale gel-filled breast implant allow advisory panel time assess additional information . In April 1992 , moratorium lift reconstruction revision subject . Every subject implant part Adjunct Study , addition offer participation registry gel-filled breast implant subject . The Adjunct Study device include round MemoryGel , Becker Expander/Prosthesis Lumera implant . In order implant gel-filled implant augmentation , woman enrol Investigational Device Exemption ( IDE ) clinical trial . A PMA Mentor 's MemoryGelâ„¢ Silicone Gel-Filled breast implant ( include Becker Expander/Breast Implants ) subsequently file FDA December 2003 , approve November 2006 ( P030053 ) . As condition approval P030053 , new enrollment Mentor 's Adjunct Study cease , woman long access Becker Expander/Breast Implants Adjustable Gel-Filled implant . The Spectra/Becker 80 Adjustable Breast Implants include Adjunct Study . This study design study safety effectiveness Mentor 's Spectra/Becker 80 Adjustable Breast Implants primary breast augmentation augmentation revision .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<criteria>Subject genetic female least 22yearsold A candidate primary breast augmentation ( general breast enlargement , postlactational involution , asymmetry ) augmentation revision ( previous augmentation siliconefilled salinefilled implant ) Signs Informed Consent Agrees return device Mentor explant necessary Agrees comply followup procedure , include return followup visit Patient US citizen Social Security Number Subject pregnant Has nurse child within three month study enrollment Been implant silicone implant breast implant ( e.g . silicone artificial joint facial implant ) . Confirmed diagnosis follow rheumatic disease syndrome : SLE , Sjogren 's syndrome , scleroderma , polymyositis , connective tissue disorder , rheumatoid arthritis , crystalline arthritis , infectious arthritis , spondyarthropathies , inflammatory arthritis , fibromyalgia , chronic fatigue syndrome Currently condition could compromise complicate wound healing Has diagnosis active cancer type Infection abscess anywhere body Demonstrates tissue characteristic clinically incompatible implant placement ( e.g . tissue damage result radiation , inadequate tissue , compromise vascularity ) Possesses condition , treatment condition , opinion investigator and/or consult physician ( ) , may constitute unwarranted surgical risk Anatomic physiologic abnormality could lead significant postoperative adverse event Demonstrates characteristic unrealistic/unreasonable risk involve surgical procedure Premalignant breast disease without subcutaneous mastectomy Untreated inappropriately treat breast malignancy , without mastectomy Are HIV positive Work Mentor study doctor directly relate anyone work Mentor study doctor Implanted metal metal device , history claustrophobia condition would make MRI scan prohibitive</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Augmentation</keyword>
	<keyword>Augmentation Revision</keyword>
</DOC>